Identification of CSPG4 as a promising target for translational combinatorial approaches in osteosarcoma

BACKGROUND: Osteosarcoma (OSA) is a highly metastatic pediatric bone tumor. Adjuvant chemotherapy and surgical resection represent standard treatments; however, the prognosis is still poor. Effective strategies are urgently needed. Chondroitin sulfate proteoglycan (CSPG)4 is a transmembrane proteogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Riccardo, Federica, Tarone, Lidia, Iussich, Selina, Giacobino, Davide, Arigoni, Maddalena, Sammartano, Federica, Morello, Emanuela, Martano, Marina, Gattino, Francesca, Maria, Raffaella De, Ferrone, Soldano, Buracco, Paolo, Cavallo, Federica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557023/
https://www.ncbi.nlm.nih.gov/pubmed/31217827
http://dx.doi.org/10.1177/1758835919855491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6557023/
https://www.ncbi.nlm.nih.gov/pubmed/31217827
http://dx.doi.org/10.1177/1758835919855491

Ejemplares similares